CSL Behring

CSL Behring

Company Less

CSL Behring

to get instant updates about 'CSL Behring' on your MyPage. Meet other similar minded people. Its Free!


All Updates

CSL Behring is one of the world's leading plasma protein biotherapeutics companies, specializing in the manufacture of therapies for the treatment of rare and serious diseases. Its line of therapies includes products for the treatment of hemophilia, von Willebrand Disease, and other bleeding disorders; immune deficiencies including primary immunodeficiency diseases (PIDD); hereditary angioedema and inherited respiratory disease. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic diseases in newborns.

Company Statistics

Parent Company: CSL Limited, (ASX:CSL), Melbourne, Australia</br>Headquarters: King of Prussia, PA</br>Employees: 9,000+Operations: In 19 countries</br>President: Paul PerreaultR&D: Marburg, Germany; Bern, Switzerland; King of Prussia, Pennsylvania, USA; Tokyo, Japan; Broadmeadows and Parkville, Victoria, Australia.


CSL Behring is a subsidiary of CSL Limited (ASX: CSL), a specialty biopharmaceutical company with headquarters in Parkville, Australia. As part of a global alignment, the CSL Behring brand was...
Read More

No feeds found

Posting your question. Please wait!...


No messages found
Suggested Pages
Tell your friends >
about this page
 Create a new Page
for companies, colleges, celebrities or anything you like.Get updates on MyPage.
Create a new Page
 Find your friends
  Find friends on MyPage from